A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens

Vaccine

Volumn 14, Issue 14, 1996, Pages 1353-1360

  Castignolles, Nathalie ^a   Morgeaux, Sylvie ^b   Gontier Jallet, Corinne ^c   Samain, Daniel ^a   Betbeder, Didier ^b   Perrin, Pierre ^c  

^a INSTITUT PASTEUR   (France)

^b Biovector Therapeutics   (France)

^c Laboratoire de Ciblage en Thérapeutique   (France)

Author keywords

Adjuvant; Polysaccharidic particles; Rabies; Vaccine

Indexed keywords

DRUG CARRIER; PALMITIC ACID; POLYSACCHARIDE; RABIES VACCINE; VIRUS ANTIGEN;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, VIRAL; DRUG CARRIERS; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; POLYSACCHARIDES; RABIES VACCINES; RABIES VIRUS;

EID: 0030267776     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00043-6     Document Type: Article

References (30)

1. Pasteur, L. Méthode pour prévenir la rage après morsure. C.R. Acad. Sci. Paris 1885, 17, 765
2. Perrin, P., Madhusudana, S., Gontier-Jallet, C., Petres, S., Tordo, N. and Merten, O.-W. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Vaccine 1995, 13, 1244
3. Ramon, G. Procédés pour accroître la production des antitoxines. Ann. Inst. Pasteur 1926, 40, 1
4. Glenny, A., Pope, C., Waddington, H. and Wallace, U. The antigenic value of toxoid precipitated by potassium alum. J. Pathol. Bacteriol. 1926, 29, 38
5. Petermann, H., Soulebot, P., Lang, R. and Branche, R. La saponine, adjuvant de l'immunité pour la vaccination des bovins contre la rage. C.R. Acad. Sci. Paris. 1970, 270, 234
6. Petermann, H., Soulebot, J., Lang, R. and Branche, R. La vaccination antirabique des carnivores et des herbivores avec un vaccin inactivé produit sur culture de tissu. Bull. Soc. Sci. Vét. Méd. Comparée Lyon. 1971, 73, 123
7. Morein, B., Lövgren, K., Höldung, S. and Sundquist, B. The ISCOM: an immunostimulating complex. Immunol. Today 1987, 8, 333
8. Baer, G., Shaddock, J., Levy, H. and Johnston, P. Interferon in rabies post-exposure prophylaxis. Progr. Rabies Control 1988, 245
9. Lin, H., Gontier, C., Saron, M.-F. and Perrin, P. A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects. Arch. Virol. 1993, 131, 307
10. Perrin, P., Joffret, M.-L, Leclerc, C., Oth, D., Sureau, P. and Thibodeau, L. Interleukin-2 increases protection against experimental rabies. Immunobiology 1988, 177, 199
11. Nunberg, J., Doyle, M., York, S. and York, C. Interleukin-2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc. Natl. Acad. Sci. USA 1989, 86, 4240
12. Schijns, V., Claassen, I., Vermeulen, A., Horzinek, M. and Osterhaus, A. Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-α, interleukin-1α, interleukin-2 and Interferon-γ on the immunogenicity of an inactivated rabies vaccine. J. Gen. Virol. 1994, 75, 55
13. Perrin, P., Thibodeau, L. and Sureau, P. Rabies immunosomes (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies. Vaccine 1985, 3, 325
14. Peyrot, M., Sautereau, A., Rabanel, J., Nguyen, F., Tocanne, J. and Samain, D. Supramolecular biovectors (SMBV): a new family of nanoparticulate drug delivery systems. Synthesis and structural characterization. Int. J. Pharmaceutics 1994, 102, 25
15. Castignolles, N., Betbeder, D., Ioualen, K. et al. Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supra molecular biovectors. Vaccine 1994, 12, 1413
16. Perrin, P., Portnoi, D. and Sureau, P. Etude de l'adsorption et de la pénétration du virus rabique: interactions avec les cellules BHK-21 et des membranes artificielles. Ann. Virol. (Inst. Pasteur) 1982, 133E, 403
17. Morgeaux, S., Tordo, N., Gontier, C. and Perrin, P. β-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus. Vaccine 1993, 11, 82
18. Perrin, P. Techniques for the preparation of rabies conjugates. Laboratory Techniques in Rabies (4th edn). WHO, Geneva, 1996 (in press)
19. Smith, P., Krohn, R., Hermanson, G. et al. Measurement of protein using bicinchonimic acid. Anal. Biochem. 1985, 150, 76
20. Pyrógenes P. Pharmacopée Européenne. (2nd edn). 1986, Vol. 2.1.h
21. Seligmann, E. The NIH test for potency. In Laboratory Techniques in Rabies (3rd Edn). WHO, Geneva, 1973, p. 279
22. Perrin, P., Versmisse, P., Delagneau, J.F., Lucas, G., Rollin, P. and Sureau, P. The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus. J. Biol. Standard. 1986, 14, 95
23. Oth, D., Mercier, G., Perrin, P., Joffret, M.-L., Sureau, P. and Thibodeau, L. The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of Interleukin-2. Cell. Immun. 1987, 108, 220
24. Perrin, P., Tino De Franco, M., Jallet, C., et al. Antigenic-specific immune response is suppressed by infection in mice with pathogenic Lyssaviruses. Res. Virol. , 1996, (in press)
25. Chirgwin, J., Przybyla, A., MacDonald, R. and Rutter, W. Isolation of biologically active ribonucleic acid from sources enriched in nuclease. Biochemistry 1979, 18, 5294
26. Chomczynski, P. and Sacchi, N. Single step method of RNA isolation by guanidium thiocyanante-phenol-chloroform extraction. Anal. Biochem. 1987, 162, 156
27. Brett, S., Dunlop, L., Liew, F. and Tite, J. Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein. Immunology 1993, 80, 306
28. Sikes, R.K., Cleary, W.F., Koprowski, H., Wiktor, T.J. and Kaplan, M.M. Effective protection of monkeys against death from street virus by post-exposure administration of tissue culture rabies vaccine. Bull. WHO 1971, 45, 1
29. Dietzschold, B., Gore, M., Casali, P. et al. Biological characterization of human monoclonal antibodies to rabies virus. J. Virol. 1990, 64, 3087
30. Chedid, L. Adjuvants of immunity. Ann. Inst. Pasteur/Immun. 1985, 136D, 283